Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

RNase L hinders hair follicle regeneration by altering immune signals.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

A patient developed a blister at the injection site after hepatitis C treatment.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Standardized methods are needed to understand how process conditions affect extracellular vesicle protein content for skin therapy.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.